50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia

06/11/2025 4 min
50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia

Listen "50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia"

Episode Synopsis

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about how monoclonal antibodies revolutionized neurologic treatment, why pregabalin link to increased heart failure, and a combined therapy that slows progression in primary progressive aphasia.

More episodes of the podcast Neurology Today in 5